Selecting the Best Breast Cancer Centres and Hospitals in India — A Congolese Patient's Guide

Author:- Dr. Dheeraj Bojwani Date Created:- 06-08-2026

Choosing a breast cancer centre means looking past a single surgeon's reputation, toward the full multidisciplinary team behind the treatment plan — a breast surgical oncologist, a medical oncologist, and a radiation oncologist, working together and reviewing your case as a genuine team. In 24 years of guiding patients through this exact decision, I have found that families often focus entirely on finding one respected surgeon, without asking whether a coordinated team stands behind them. Given how often breast cancer patients in this region present at a later stage, where treatment sequencing genuinely matters, this guide sets out, plainly, how a Congolese patient should judge both. None of this is meant to add to a difficult moment — it is meant to make the choice ahead feel more manageable, with clear, specific questions to ask.

Healing Journeys of Congolese Patients

Congolese Patients Share Their Experience

Key Takeaways

• The guide explains that choosing a breast cancer centre should involve the entire multidisciplinary team, not just the surgeon. A breast surgical oncologist, medical oncologist and radiation oncologist should work together to develop and review the treatment plan.
• The guide stresses the importance of complete staging before finalising treatment, including hormone receptor and HER2 status. These results help determine which treatments are appropriate and can influence whether chemotherapy is given before or after surgery.
• The page 1 weighting graphic gives 47% importance to the surgeon and 53% to the multidisciplinary team, showing that coordinated team care carries slightly greater weight, particularly when treatment involves surgery, chemotherapy and radiotherapy.
• The page 3 criteria chart places a genuine multidisciplinary tumour board at the top, followed by named surgeon case volume, complete staging, on-site radiotherapy and honest treatment-sequence assessment. Experience with the patient's exact stage and subtype is also highlighted.
• The guide warns that treatment quotations may leave out important components, particularly reconstruction or radiotherapy. Patients should therefore request an itemised estimate and ask how the cost will change if treatment needs to be staged over several months.
• For Congolese patients, the guide recommends sending actual pathology and imaging results, confirming hormone receptor and HER2 status, maintaining a 15–20% financial margin and planning for an extended stay when treatment is likely to involve multiple stages. Medical and attendant visas and a current yellow-fever certificate should also be arranged.
• The guide identifies four warning signs: no multidisciplinary tumour board, no hormone receptor or HER2 testing, radiotherapy outsourced elsewhere and pressure to pay the full balance before receiving a complete written treatment plan.

Quick Facts

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

Treatment

Breast Cancer Treatment

Patients

Congolese Patients

First Assessment

Complete staging, hormone receptor and HER2 testing

Key Specialist

Breast Surgical Oncologist

Decision Weighting

Surgeon 47% / Multidisciplinary Team 53%

Team

Surgical, medical and radiation oncologists

Team Check

Genuine multidisciplinary tumour board

Treatment Sequence

Assess whether chemotherapy comes before or after surgery

Radiotherapy

Preferably available on-site

Reconstruction

Confirm options and timing where relevant

Accreditation

NABH or JCI

Cost Check

Written, itemised full treatment estimate

Financial Buffer

15–20%

Medical Records

Pathology and imaging results

Visa

Paper medical and attendant visa

Entry Requirement

Current yellow-fever certificate

Follow-Up

Complete treatment and follow-up plan

Key Warning

Avoid centres without genuine multidisciplinary coordination

Decision Principle

Choose coordinated breast cancer care, not a surgeon alone.

In Brief

For Congolese patients seeking breast cancer treatment in India, the guide recommends complete staging, a named breast oncology surgeon and a genuine multidisciplinary team capable of coordinating surgery, chemotherapy and radiotherapy. Patients should also confirm reconstruction options, obtain a transparent quotation and establish the treatment sequence before travelling.

First, Insist on Complete Staging Before Any Plan

Before comparing centres, make sure your evaluation includes full staging, along with hormone receptor and HER2 status testing. These results shape which treatments will actually work for your specific cancer, and a treatment plan built without them is built on incomplete information.

This matters particularly for patients presenting at a later stage, where the sequence of treatment — whether chemotherapy comes before or after surgery, for instance — can meaningfully affect both the surgical outcome and the overall treatment timeline. A centre that proposes a plan before this staging is complete is working from an incomplete picture.

Two Decisions, Weighed

Choosing well depends on two things: the surgeon's own breast oncology experience, and the hospital's genuine multidisciplinary team. For breast cancer specifically, the surrounding team carries slightly more weight than the surgeon alone, because so much of what determines outcome depends on whether surgery, chemotherapy, and radiotherapy are properly sequenced together, particularly for later-stage cases.

Part One: Choosing the Surgeon

These three points matter more than a hospital's overall reputation or general marketing claims.

1. A named breast oncology surgeon with genuine case volume — ask directly how many breast cancer cases they treat in a typical year.
2. Experience with your exact stage and subtype, since a later-stage presentation, common among Congolese patients, is a genuinely different case than early-stage disease.
3. An honest treatment-sequence assessment, explaining clearly whether chemotherapy should come before or after surgery for your specific case.

A surgeon's overall experience with breast cases does not automatically indicate deep familiarity with later-stage, locally advanced disease specifically. Ask directly what proportion of their caseload involves patients presenting at stage III or later, since this is the pattern most Congolese patients will actually resemble.

Part Two: Verifying the Multidisciplinary Team

This is the part most families cannot judge from a brochure alone, which is exactly why it needs direct, specific questions rather than general reassurance.

4. A genuine multidisciplinary tumour board, where surgical, medical, and radiation oncologists actually meet to discuss your case together.
5. On-site radiotherapy, not outsourced or referred elsewhere, so your full pathway remains coordinated under one team.
6. Reconstruction options discussed clearly, if relevant to your case, including realistic timing relative to other treatment.
7. Full staging including hormone receptor and HER2 status, confirmed before any treatment plan is finalised.
8. NABH accreditation in India, or JCI internationally, auditing patient safety and clinical governance in depth.

What the quote doesn't always show

In 24 years of reviewing these estimates, I have found the disputes almost never concern the headline number — they concern what it silently left out: reconstruction quoted separately and disclosed only once a mastectomy is already underway, or radiotherapy priced apart from the rest of the treatment. Get every line item in writing before paying any deposit, and never pay the full balance before treatment.

Given how often treatment for later-stage disease genuinely unfolds in stages, over months, it is worth asking specifically how the quote handles a treatment plan that changes partway through, rather than assuming the initial figure covers every possible path your case might take.

What a Congolese Patient Should Weigh in Particular

Beyond verifying the surgeon and multidisciplinary team, a handful of practical realities specific to travelling from the DRC deserve their own attention.

Send your actual pathology and imaging results, not just a description of your diagnosis, to every centre being compared.

Ask specifically about hormone receptor and HER2 status, and how these results shape the recommended treatment.

Currency and budget. The Congolese franc has weakened considerably against the dollar (roughly CDF 2,300–2,350 per US$1 in mid-2026, and it moves); budget with a 15–20% margin above the written estimate.

Visa timing. DRC passport holders need a paper medical visa through the Embassy of India in Kinshasa (Avenue Batetela, Gombe), typically around two weeks once the hospital's invitation letter is ready; apply for the attendant visa in the same batch.

Yellow fever certificate, current and dated at least 10 days before travel.

Plan for an extended stay — a complete treatment pathway for later-stage disease often spans weeks or months, not a single visit.

Four signals that should make you pause

• No multidisciplinary tumour board, only a single surgeon making decisions independently.
• No hormone receptor or HER2 testing behind the treatment plan.
• Radiotherapy outsourced elsewhere rather than delivered on-site.
• Pressure to pay the full balance before a written, complete treatment plan exists.

Weigh these signals together rather than in isolation, particularly given how much later-stage breast cancer treatment depends on careful sequencing across multiple specialists working from the same complete picture of your case.

Send these two short lists in writing, by email, before agreeing to travel. A genuinely complete breast cancer centre will answer both directly and specifically; one built around a single surgeon may struggle to answer the team-related questions at all.

A closing word

Breast cancer treatment succeeds as much on the coordinated team behind the plan as on the surgeon's individual skill, and this matters even more when a case presents at a later stage, as is common among Congolese patients. A named, experienced breast oncology surgeon backed by a genuine multidisciplinary tumour board and on-site radiotherapy is the baseline worth insisting on before any deposit is paid. If you can share your pathology and imaging results, I am glad to review them honestly, including telling you if a proposed centre's team does not look sufficiently complete for your specific case.

Sources

• 🌐 National Medical Commission of India — verify any surgeon's registration · nmc.org.in
• 🌐 National Accreditation Board for Hospitals & Healthcare Providers (NABH) · nabh.co
• 🌐 Embassy of India, Kinshasa — medical visa requirements · eoikinshasa.gov.in
• 🌐 "Stage at diagnosis of breast cancer in sub-Saharan Africa," The Lancet Global Health · thelancet.com
• 🌐 World Health Organization — yellow fever vaccination requirements · who.int/health-topics/yellow-fever

Frequently Asked Questions by Congolese Patients about Selecting the Best Breast Cancer Centres and Hospitals in India

Why is a multidisciplinary team important?

Breast cancer treatment may involve surgery, chemotherapy and radiotherapy, so coordination between specialists is important when deciding the correct sequence.

What tests should be completed before treatment planning?

The guide recommends full staging together with hormone receptor and HER2 status testing before finalising the treatment plan.

How is the surgeon evaluated?

Patients should ask how many breast cancer cases the surgeon treats annually and whether they have experience with the patient's specific stage and subtype.

What is a multidisciplinary tumour board?

It is a team-based review in which surgical, medical and radiation oncologists discuss the patient's case together.

Should radiotherapy be available at the same centre?

The guide recommends on-site radiotherapy where possible so the treatment pathway remains coordinated under the same team.

What should patients ask about reconstruction?

Patients should ask what reconstruction options are available and when reconstruction would fit into the overall treatment sequence.

What should the cost estimate include?

Patients should obtain a written, itemised estimate and specifically check whether radiotherapy and reconstruction are included or priced separately.

What records should Congolese patients send?

They should send their actual pathology and imaging results, rather than only providing a general description of the diagnosis.

How much financial buffer is recommended?

The guide recommends keeping a 15–20% margin above the written treatment estimate.

What are the main warning signs?

Be cautious if there is no multidisciplinary tumour board, incomplete hormone receptor or HER2 testing, outsourced radiotherapy or pressure to pay the full balance before a complete written plan.

Page Summary

This five-page guide focuses on selecting a breast cancer centre based on multidisciplinary expertise, complete staging and coordinated treatment sequencing. The page 1 graphic gives slightly greater weight to the multidisciplinary team, while page 3 ranks tumour-board coordination and complete staging among the leading criteria. Page 4 highlights cost transparency, travel planning and the treatment pathway.

Citation Block

Field	Information
Topic	Breast Cancer Treatment in India for Congolese Patients
Treatment	Breast Cancer Treatment
Patients	Congolese Patients
First Assessment	Staging, hormone receptor and HER2 testing
Key Specialist	Breast Surgical Oncologist
Decision Weighting	Surgeon 47% / Team 53%
Team Check	Multidisciplinary tumour board
Treatment Sequence	Chemotherapy and surgery timing
Radiotherapy	On-site preferred
Cost Check	Written, itemised estimate
Financial Buffer	15–20%
Medical Records	Pathology and imaging
Visa	Medical and attendant visa
Follow-Up	Complete treatment plan
Warning Signs	No tumour board, incomplete testing, outsourced radiotherapy or early full-payment pressure
Key Decision	Choose coordinated multidisciplinary care